micro chapter 17
Terms
undefined, object
copy deck
- T CELL
- A TYPE OF LYMPHOCYTE, WHICH DEVELOPS FROM A STEM CELL PROCESSED IN THE THYMUS GLAND, THAT IS RESPONSIBLE FOR CELL-MEDIATED IMMUNITY
- ARTIFICIALLY ACQUIRED ACTIVE IMMUNITY
- THE PRODUCTION OF ANTIBODIES BY THE BODY IN RESPONSE TO A VACCINATION
- IMMUNOTOXIN
- AN IMMUNOTHERAPEUTIC AGENT CONSISTING OF A POISON BOUND TO A MONOCLONAL ANTIBODY
- ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC)
- THE KILLING OF ANTIBODY-COATED CELLS BY NATURAL KILLER CELLS AND PHAGOCYTES
- ACTIVATED MACROPHAGE
- A MACROPHAGE THAT HAS INCREASED PHAGOCYTIC ABILITY AND OTHER FUNCTIONS AFTER EXPOSURE TO MEDIATORS RELEASED BY T CELLS AFTER STIMULATION BY ANTIGENS
- GLOBULIN
- THE CLASS OF PROTEINS THAT INCLUDES ANTIBODIES
- CYTOTOXIC T (TC) CELLS
- A SPECIALIZED T CELL THAT DESTROYS INFECTED CELLS PRESENTING ANTIGENS
- CHEMOKINE
- A CYTOKINE THAT INDUCES, BY CHEMOTAXIS, THE MIGRATION OF LEUKOCYTES INTO INFECTED AREAS
- PRIMARY RESPONSE
- ANTIBODY PRODUCTION IN RESPONSE TO THE FIRST CONTACT WITH AN ANTIGEN
- SUPPRESSOR T CELLS (TS)
- A T CELL THAT IS THOUGHT TO END AN IMMUNE RESPONSE AFTER AN ANTIGEN IS NO LONGER PRESENT
- PLASMA CELL
- A CELL THAT AN ACTIVATED B CELL DIFFERENTIATES INTO; PLASMA CELLS MANUFACTURE SPECIFIC ANTIBODIES
- IgA
- THE CLASS OF ANTIBODIES FOUND IN SECRETIONS
- IgG
- THE MOST ABUNDANT CLASS OF ANTIBODIES IN SERUM
- IMMUNITY
- THE BODY'S DEFENSE AGAINST PARTICULAR PATHOGENIC MICROORGANISMS; ALSO CALLED SPECIFIC RESISTANCE
- IMMUNE SERUM GLOBULIN
- THE SERUM FRACTION CONTAINING INMMUNOGLOBULINS (ANTIBODIES); ALSO CALLED GAMMA GLOBULIN
- ANTIBODY TITER
- THE AMOUNT OF ANTIBODY IN SERUM
- AGGLUTINATION
- A JOINING TOGETHER OR CLUMPING OF CELLS
- TARGET CELL
- AN INFECTED BODY CELL TO WHICH DEFENSIVE CELLS OF THE IMMUNE SYSTEM BIND
- CYTOKINE
- A SMALL PROTEIN RELEASED FROM HUMAN CELLS IN RESPONSE TO BACTERIAL INFECTION; DIRECTLY OR INDIRECTLY MAY INDUCE FEVER, PAIN, OR T-CELL PROLIFERATION
- NATURAL KILLER (NK) CELL
- A LYMPHOID CELL THAT DESTROYS TUMOR CELLS AND VIRUS-INFECTED CELLS
- MONOCLONAL ANTIBODY
- A SPECIFIC ANTIBODY PRODUCED IN VITRO BY A CLONE OF B CELLS HYBRIDIZED WITH CANCEROUS CELLS
- MEMORY RESPONSE
- A RAPID RISE IN ANTIBODY TITER FOLLOWING EXPOSURE TO AN ANTIGEN AFTER THE PRIMARY RESPONSE TO THAT ANTIGEN; ALSO CALLED ANAMESTIC RESPONSE OR SECONDARY RESPONSE
- MONOMER
- A SMALL MOLECULE THAT COLLECTIVELY COMBINES TO FORM POLYMERS
- IMMUNOGLOBULIN (IG)
- A PROTEIN (ANTIBODY) FORMED IN RESPONSE TO AN ANTIGEN AND CAN REACT WITH THAT ANTIGEN
- MAJOR HISTOCOMPATIBILITY COMPLEX (MHC)
- THE GENES THAT CODE FOR HISTOCOMPATIBILITY ANTIGENS; ALSO KNOWN AS HUMAN LEUKOCYTE ANTIGEN (HLA) COMPLEX
- ACQUIRED IMMUNITY
- THE ABILITY, OBTAINED DURING THE LIFE OF THE INDIVIDUAL, TO PRODUCE SPECIFIC ANTIBODIES
- T-DEPENDENT ANTIGEN
- AN ANTIGEN THAT WILL STIMULATE THE FORMATION OF ANTIBODIES ONLY WITH THE ASSISTANCE OF HELPER T CELLS
- DELAYED HYPERSENSITIVITY T (TD) CELLS
- A SPECIALIZED T CELL THAT PRODUCES LYMPHOKINES IN TYPE IV HYPERSENSITIVITIES
- T-INDEPENDENT ANTIGEN
- AN ANTIGEN THAT WILL STIMULATE THE FORMATION OF ANTIBODIES WITHOUT THE ASSISTANCE OF HELPER T CELLS
- ANTIGENIC DETERMINANT
- A SPECIFIC REGION ON THE SURFACE OF AN ANTIGEN AGAINST WHICH ANTIBODIES ARE FORMED; ALSO CALLED EPITOPE
- INTERLEUKIN
- A CHEMICAL THAT CAUSES T-CELL PROLIFERATION
- CHIMERIC MONOCLONAL ANTIBODY
- A GENETICALLY ENGINEERED ANTIBODY MADE OF HUMAN CONSTANT REGIONS AND MOUSE VARIABLE REGIONS
- HAPTEN
- A SUBSTANCE OF LOW MOLECULAR WEIGHT THAT DOES NOT CAUSE THE FORMATION OF ANTIBODIES BY ITSELF BUT DOES SO WHEN COMBINED WITH A CARRIER MOLECULE
- HUMORAL IMMUNITY
- IMMUNITY PRODUCED BY ANTIBODIES DISSOLVED IN BODY FLUIDS, MEDIATED BY B CELLS; ALSO CALLED ANTIBODY-MEDIATED IMMUNITY
- IgD
- THE CLASS OF ANTIBODIES FOUND ON B CELLS
- CLONAL SELECTION
- THE DEVELOPMENT OF CLONES OF B AND T CELLS AGAINST A SPECIFIC ANTIGEN
- SEROLOGY
- THE BRANCH OF IMMUNOLOGY THAT STUDIES BLOOD SERUM AND ANTIGEN-ANTIBODY REACTIONS IN VITRO
- LYSIS
- (1)DESTRUCTION OF A CELL BY THE RUPTURE OF THE PLASMA MEMBRANE, RESULTING IN A LOSS OF CYTOPLASM (2) IN DISEASE, A GRADUAL PERIOD OF DECLINE
- VALENCE
- THE COMBINING CAPACITY OF AN ATOM OR A MOLECULE
- DENDRITIC CELL
- A TYPE OF ANTIGEN-PRESENTING CELL CHARACTERIZED BY A LONG FINGERLIKE EXTENSIONS; FOUND IN LYMPHATIC TISSUE AND SKIN
- ANTIGEN-ANTIBODY COMPLEX
- THE COMBINATION OF AN ANTIGEN WITH THE ANTIBODY THAT IS SPECIFIC FOR IT; THE BASIS OF IMMUNE PROTECTION AND MANY DIAGNOSTIC TESTS
- APOPTOSIS
- THE NATURAL PROGRAMMED DEATH OF A CELL; THE RESIDUAL FRAGMENTS ARE DISPOSED OF BY PHAGOCYTOSIS
- ANTIGEN-PRESENTING CELL (APC)
- A MACROPHAGE OR DENDRITIC CELL THAT ENGULFS AN ANTIGEN AND PRESENTS FRAGMENTS TO T CELLS
- STEM CELL
- A FETAL CELL THAT GIVES RISE TO RED BONE MARROW, BLOOD CELLS AND B AND T CELLS
- ANAMNESTIC RESPONSE
- MEMORY RESPONSE
- ANTIGEN-BINDING SITES
- A SITE ON AN ANTIBODY THAT BINDS TO AN ANTIGENIC DETERMINANT
- ARTIFICIALLY ACQUIRED PASSIVE IMMUNITY
- THE TRANSFER OF HUMORAL ANTIBODIES FORMED BY ONE INDIVIDUAL TO A SUSCEPTIBLE INDIVIDUAL, ACCOMPLISHED BY THE INJECTION OF ANTISERUM
- ANTIGEN
- ANY SUBSTANCE THAT CAUSES ANTIBODY FORMATION AND REACTS ONLY WITH ITS SPECIFIC ANTIBODY; ALSO CALLED IMMUNOGEN
- VACCINATION
- THE PROCESS OF CONFERRING IMMUNITY BY ADMINISTERING A VACCINE; ALSO CALLED IMMUNIZATION
- MEMORY CELLS
- A LONG-LIVED B OR T CELL RESPONSIBLE FOR THE MEMORY, OR SECONDARY, RESPONSE
- VACCINE
- A PREPARATION OF KILLED, INACTIVATED, OR ATTENUATED MICROORGANISMS OR TOXOIDS TO INDUCE ARTIFICIALLY ACQUIRED ACTIVE IMMUNITY
- INFLAMMATION
- A HOST RESPONSE TO TISSUE DAMAGE CHARACTERIZED BY REDNESS, PAIN, HEAT, AND SWELLING; AND SOMETIMES LOSS OF FUNCTION
- NATURALLY ACQUIRED ACTIVE IMMUNITY
- ANTIBODY PRODUCTION IN RESPONSE TO AN INFECTIOUS DISEASE
- ANTIBODY
- A PROTEIN PRODUCED BY THE BODY IN RESPONSE TO AN ANTIGEN, AND CAPABLE OF COMBINING SPECIFICALLY WITH THAT ANTIGEN
- CD (CLUSTER OF DETERMINATION)
- NUMBER ASSIGNED TO AN EPITOPE ON A SINGLE ANTIGEN, FOR EXAMPLE, CD4 PROTEIN, WHICH IS FOUND ON HELPER T CELLS
- ANTIGEN RECEPTORS
- AN ANTIBODY-LIKE MOLECULE ON B AND T CELLS THAT ENABLES THEM TO RECOGNIZE AND BIND TO THEIR SPECIFIC ANTIGEN
- HELPER T (TH) CELL
- A SPECIALIZED T CELL THAT OFTEN INTERACTS WITH AN ANTIGEN BEFORE B CELLS INTERACT WITH THE ANTIGEN
- NATURALLY ACQUIRED PASSIVE IMMUNITY
- THE NATURAL TRANSFER OF HUMORAL ANTIBODIES, FOR EXAMPLE, TRANSPLACENTAL TRANSFER
- IgM
- THE FIRST CLASS OF ANTIBODIES TO APPEAR AFTER EXPOSURE TO AN ANTIGEN
- CLONAL DELETION
- THE ELIMINATION OF B AND T CELLS THAT REACT WITH SELF
- CELL-MEDIATED IMMUNITY
- AN IMMUNE RESPONSE THAT INVOLVES T CELLS BINDING TO ANTIGENS PRESENTED ON INFECTED CELLS; T CELLS THEN DIFFERENTIATE INTO SEVERAL TYPES OF EFFECTOR T CELLS, INCLUDING HELPER AND CYTOTOXIC
- B CELL
- A TYPE OF LYMPHOCYTE; DIFFERENTIATES INTO ANTIBODY-SECRETING PLASMA CELLS AND MEMORY CELLS
- IgE
- THE CLASS OF ANTIBODIES INVOLVED IN HYPERSENSITIVITIES
- HYBRIDOMA
- A CELL MADE BY FUSING AN ANTIBODY-PRODUCING B CELL WITH A CANCER CELL
- SELF-TOLERANCE
- THE ABILITY OF AN ORGANISM TO RECOGNIZE AND NOT MAKE ANTIBODIES AGAINST SELF
- PERFORIN
- PROTEIN THAT MAKES A PORE IN A TARGET CELL MEMBRANE, RELEASED BY TC CELLS